Company details

About

Atea’s most advanced antiviral drug candidate, AT-527, is being evaluated in a Phase 2 clinical trial in the US for the treatment of patients with moderate COVID-19 and risk factors for poor outcomes

icon

Number of employees

5001 - 10000

icon

Main industry

Information Technology

icon

Industry tags

icon

Headquarters

Oslo

icon

Country

Norway

Sign up to uncover company details

5 free credit every month

Employee contacts

Name

Job Title

Email

Phone

Co-Founder and Director

Uncover details

Sales Director

Uncover details

Solutions Architect

Uncover details

Reach Decision Makers
at Atea

5 Free credits every month!

Sign up now to uncover all the contact details